For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Sagimet Biosciences Inc (NASDAQ: SGMT) closed the day trading at $6.46 up 6.16% from the previous closing price of $6.09. In other words, the price has increased by $6.16 from its previous closing price. On the day, 0.5 million shares were traded. SGMT stock price reached its highest trading level at $6.47 during the session, while it also had its lowest trading level at $6.08.
Ratios:
For a better understanding of SGMT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.04 and its Current Ratio is at 13.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Wedbush on August 11, 2025, initiated with a Outperform rating and assigned the stock a target price of $28.
On July 24, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $28.Canaccord Genuity initiated its Buy rating on July 24, 2025, with a $28 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 20 ’25 when Kemble George sold 37,688 shares for $7.69 per share. The transaction valued at 289,979 led to the insider holds 81,005 shares of the business.
GEORGE KEMBLE bought 37,688 shares of SGMT for $295,851 on Nov 20 ’25. On Jul 21 ’25, another insider, Happel David, who serves as the President & CEO of the company, sold 65,478 shares for $9.13 each. As a result, the insider received 598,115 and left with 689,722 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 210089536 and an Enterprise Value of 93511528.
Stock Price History:
The Beta on a monthly basis for SGMT is 3.43, which has changed by 0.305794 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, SGMT has reached a high of $11.41, while it has fallen to a 52-week low of $1.73. The 50-Day Moving Average of the stock is -14.71%, while the 200-Day Moving Average is calculated to be 4.81%.
Shares Statistics:
Over the past 3-months, SGMT traded about 536.40K shares per day on average, while over the past 10 days, SGMT traded about 519680 shares per day. A total of 31.00M shares are outstanding, with a floating share count of 26.33M. Insiders hold about 19.03% of the company’s shares, while institutions hold 32.70% stake in the company. Shares short for SGMT as of 1763078400 were 2989800 with a Short Ratio of 5.57, compared to 1760486400 on 2751347. Therefore, it implies a Short% of Shares Outstanding of 2989800 and a Short% of Float of 10.41.
Earnings Estimates
The stock of Sagimet Biosciences Inc (SGMT) is currently being evaluated by 8.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.41, with high estimates of -$0.38 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$1.64 and -$1.73 for the fiscal current year, implying an average EPS of -$1.69. EPS for the following year is -$1.91, with 8.0 analysts recommending between -$1.65 and -$2.14.
